Immunobiochem Corporation is a biotechnology company committed to addressing unmet medical need in oncology through research and development of novel, targeted biological therapeutics. ImmunoBiochem is headquartered in Ontario, Canada, and draws on the vast expertise of cancer researchers and clinicians located in the biomedical hub of downtown Toronto.
ImmunoBiochem has pioneered a proprietary technology to address the challenge of cancer heterogeneity in solid tumors with its tumor microenvironment-targeted antibody-drug conjugates (ADCs). ADCs comprise a novel class of potentiated biological therapeutics, combining the targeting capabilities of monoclonal antibodies with the cytotoxic properties of small molecule cancer drugs to selectively and specifically destroy cancer cells while minimizing damage to normal tissues. ADCs comprise an antibody component linked to a cytotoxic molecule via a stable linker that is uniquely engineered to deliver and release the cytotoxic payload in cancer cells.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 661 Uiversity Avenue, Suite 1300, 13102h,canada
- Phone
- 416.897.2789
- co****@****hem.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- immunobiochem.com
- HQ
- Toronto, Ontario
Immunobiochem Corporation Questions
Immunobiochem Corporation's helpline number is 416.897.2789
Immunobiochem Corporation's website is immunobiochem.com
Immunobiochem Corporation's LinkedIn profile is https://ca.linkedin.com/company/immunobiochem
Immunobiochem Corporation has
3 employees.
View email and phone details for 3
employees at Immunobiochem Corporation.
Immunobiochem Corporation's industry is
Biotechnology Research
Immunobiochem Corporation's top competitors are
Life Sciences Ontario,
Proteinqure,
Virica Biotech,
Mesosil,
Epiloid Biotechnology,
Noa Therapeutics,
Ccrm,
Aps Pharma,
Bough Biosciences,
Bluerock Therapeutics.
Immunobiochem Corporation's support email address is contact@immunobiochem.com
Immunobiochem Corporation's categories are Biotechnology Research
Immunobiochem Corporation's founding year is 2007
